Related Experiment Video

Updated: Apr 19, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.6K

Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection

Nicolas Goossens, Francesco Negro1

  • 1Divisions of Clinical Pathology and of Gastroenterology and Hepatology, Geneva University Hospital, 4 rue Gabrielle-Perret-Gentil, 1211 Geneva 4, Switzerland. Francesco.Negro@hcuge.ch.

Reviews on Recent Clinical Trials
|December 18, 2014
PubMed

Insights

Non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR), and hepatitis C virus (HCV) infection often coexist. Understanding their complex interplay is crucial for patient outcomes and treatment strategies.

Area of Science:

  • Hepatology
  • Endocrinology
  • Virology

Background:

  • Non-alcoholic fatty liver disease (NAFLD), insulin resistance (IR), and hepatitis C virus (HCV) infection are prevalent conditions that frequently overlap.
  • HCV infection, especially genotype 3, can cause viral steatosis, mimicking NAFLD but with distinct clinical implications.
  • HCV patients exhibit an elevated risk for developing IR and type 2 diabetes (T2D).

Purpose of the Study:

  • To elucidate the complex relationship between NAFLD, IR, and HCV infection.
  • To highlight the impact of T2D on liver disease progression and treatment response in HCV patients.
  • To explore potential links between HCV and cardiovascular events.

Main Methods:

  • Review of epidemiological and experimental data.
  • Analysis of the clinical implications of viral steatosis versus NAFLD.
  • Examination of T2D's effects on fibrosis, HCC incidence, and treatment outcomes in HCV.
  • Discussion of cardiovascular risk in HCV patients.

Main Results:

  • HCV can induce steatosis with different prognoses than NAFLD.
  • T2D exacerbates liver fibrosis, increases hepatocellular carcinoma (HCC) risk, and impairs treatment response in HCV patients.
  • A potential increase in cardiovascular events among HCV patients is suggested.

Conclusions:

  • The cohabitation of NAFLD, IR, and HCV presents a complex clinical challenge.
  • T2D significantly worsens liver-related outcomes and treatment efficacy in HCV patients.
  • Further investigation into cardiovascular risks associated with HCV is warranted.

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.1K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
66
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
20
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
15
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
17
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
24
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.5K